BYNEF yields 3.01% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, BYNEF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BYNEF + PFE for your $10,000?
Banyan Tree Holdings Limited, an investment holding company, develops, operates, and manages resorts, hotels, spas, and residences in Singapore, South East Asia, Indian Oceania, the Middle East, North East Asia, and internationally. It operates through Hotel Investments, Property Sales, and Fee-Based segments. The company engages in the hotel and restaurant operations; sale of hotel villas or suites to investors under the leaseback scheme; and development and sale of vacation homes in Laguna Phuket, as well as in the land development and sales activities. It is also involved in the management of an asset-backed destination club and private-equity funds; sale of merchandise; provision of architectural and design services; ownership and management of golf courses; and holding of land plots. In addition, the company provides tourist transportation, management consultancy, marketing, business management, investment management and related consulting, and tourism management consultancy services; operation and ancillary services related to the hospitality industry; consultation and management services of the international hotels marketing; purchasing and project services for hotels, resorts, and spas; and designing, planning, and consultancy services for hotels, resorts and spas, as well as owns and manages the intellectual property. Further, it is involved in the holiday club membership and property holding operations; operation, investment, and rental of retail outlets and offices; and development of residential properties. The company manages 29 hotels and resorts, 63 spas, 72 retail galleries, and 3 golf courses. Banyan Tree Holdings Limited was founded in 1984 and is based in Singapore.
Full BYNEF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.